Silence Therapeutics Plc - ADR - SLN - stock price prediction, stock price target, analyst ratings from 6 analysts

Silence Therapeutics Plc - ADR has a share price target of US$ 34, revenue growth forecast of -55.1%, and profit growth estimate of -119.9% for FY25, based on top 6 analyst calls.